Literature DB >> 22711433

Bone-vascular cross-talk.

Gérard M London1.   

Abstract

Increasing numbers of cross-sectional studies on general populations and chronic kidney disease (CKD) or end-stage renal disease (ESRD) patients have reported relationships between cardiovascular calcifications and bone disorders, including osteoporosis, osteopenia and high or low bone activity. The mechanisms underlying this bone-cardiovascular axis and biological links between bone and arterial abnormalities are suggestive of bone-vascular cross-talk. The nature of these links is not well understood and could result from: 1) common factors acting on bone remodeling and arterial calcification; 2) compromised bone blood supply responsible for arteriosclerosis of bone vessels and reduced perfusion; and/or 3) direct action of bone cells (osteoblasts/osteocytes) on vascular biology and structure. Inflammation and accumulation of reactive oxygen species are the principal common pathways linking bone and arterial pathologies.

Entities:  

Mesh:

Year:  2012        PMID: 22711433     DOI: 10.5301/jn.5000187

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  13 in total

1.  Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Geoffrey Block; Jason Stubbs; Gerard Smits; Michel Chonchol; Makoto Miyazaki
Journal:  Am J Kidney Dis       Date:  2017-08-09       Impact factor: 8.860

2.  Calcification in arteriovenous fistula blood vessels may predict arteriovenous fistula failure: a 5-year follow-up study.

Authors:  Aleksandar Jankovic; Tatjana Damjanovic; Zivka Djuric; Jelena Marinkovic; Georg Schlieper; Petar Djuric; Jelena Tosic Dragovic; Ana Bulatovic; Milos Mitrovic; Jovan Popovic; Jürgen Floege; Nada Dimkovic
Journal:  Int Urol Nephrol       Date:  2017-01-25       Impact factor: 2.370

3.  Association of matrix Gla protein gene functional polymorphisms with loss of bone mineral density and progression of aortic calcification.

Authors:  D Tuñón-Le Poultel; J B Cannata-Andía; P Román-García; J B Díaz-López; E Coto; C Gómez; M Naves-Díaz; I Rodríguez
Journal:  Osteoporos Int       Date:  2013-11-27       Impact factor: 4.507

4.  Mesenchymal stem cells recruited by active TGFβ contribute to osteogenic vascular calcification.

Authors:  Weishan Wang; Changjun Li; Lijuan Pang; Chenhui Shi; Fengjing Guo; Anmin Chen; Xu Cao; Mei Wan
Journal:  Stem Cells Dev       Date:  2014-03-20       Impact factor: 3.272

5.  TGFβ3 recruits endogenous mesenchymal stem cells to initiate bone regeneration.

Authors:  Moyuan Deng; Tieniu Mei; Tianyong Hou; Keyu Luo; Fei Luo; Aijun Yang; Bo Yu; Hao Pang; Shiwu Dong; Jianzhong Xu
Journal:  Stem Cell Res Ther       Date:  2017-11-10       Impact factor: 8.079

6.  Links between arterial stiffness and bone mineral density in middle-aged and elderly Chinese individuals: a cross-sectional study.

Authors:  Meng Zhang; Lijuan Bai; Jing Kang; Jing Ge; Wen Peng
Journal:  BMJ Open       Date:  2019-08-10       Impact factor: 2.692

7.  Association of mineral content outside of bone with coronary artery calcium and 1-year cardiovascular prognosis in maintenance hemodialysis patients.

Authors:  Yuqin Xiong; Jiameng Li; Si Sun; Mei Han; Ruoxi Liao; Yupei Li; Liya Wang; Liping Lin; Qiang Liu; Baihai Su
Journal:  Artif Organs       Date:  2019-04-25       Impact factor: 3.094

Review 8.  Mechanisms of vascular calcification in CKD-evidence for premature ageing?

Authors:  Catherine M Shanahan
Journal:  Nat Rev Nephrol       Date:  2013-09-10       Impact factor: 28.314

Review 9.  Risk of high dietary calcium for arterial calcification in older adults.

Authors:  John J B Anderson; Philip J Klemmer
Journal:  Nutrients       Date:  2013-09-30       Impact factor: 5.717

10.  Prevalence of Vertebral Fractures and Their Prognostic Significance in the Survival in Patients with Chronic Kidney Disease Stages 3‒5 Not on Dialysis.

Authors:  Cristina Castro-Alonso; Luis D'Marco; Jaume Pomes; Monserrat Del Amo Conill; Ana Isabel García-Diez; Pablo Molina; María Jesús Puchades; José Manuel Valdivielso; Verónica Escudero; Jordi Bover; Juan Navarro-González; Begoña Ribas; Luis Manuel Pallardo; José Luis Gorriz
Journal:  J Clin Med       Date:  2020-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.